Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.

PubWeight™: 2.21‹?› | Rank: Top 2%

🔗 View Article (PMC 2745661)

Published in PLoS Pathog on October 02, 2009

Authors

Cary A Moody1, Laimonis A Laimins

Author Affiliations

1: Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.

Articles citing this

(truncated to the top 100)

Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99

Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96

Modulation of DNA damage and repair pathways by human tumour viruses. Viruses (2015) 1.49

The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol (2011) 1.49

Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45

Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe (2014) 1.42

Snapshots: chromatin control of viral infection. Virology (2013) 1.39

Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37

Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33

The papillomavirus E2 proteins. Virology (2013) 1.30

Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J Virol (2013) 1.28

The papillomavirus E7 proteins. Virology (2013) 1.28

Cancer associated human papillomaviruses. Curr Opin Virol (2012) 1.25

Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23

Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14

Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells. PLoS Pathog (2013) 1.13

Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol (2011) 1.11

Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol (2013) 1.09

Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol (2013) 1.07

CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol (2014) 1.05

An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog (2011) 1.04

Bocavirus infection induces a DNA damage response that facilitates viral DNA replication and mediates cell death. J Virol (2010) 1.03

Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication. PLoS Pathog (2010) 1.03

ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog (2013) 1.02

The E1 proteins. Virology (2013) 1.02

Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome. PLoS Pathog (2014) 1.00

Oxidative stress and HPV carcinogenesis. Viruses (2013) 1.00

Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA. PLoS Pathog (2013) 1.00

What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe (2014) 1.00

Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 0.99

Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J Virol (2010) 0.98

Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation. Front Microbiol (2012) 0.98

Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol (2013) 0.97

p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol (2011) 0.96

Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. J Virol (2013) 0.96

Baculovirus infection induces a DNA damage response that is required for efficient viral replication. J Virol (2011) 0.96

The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95

Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1. J Virol (2014) 0.94

DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein Apoptin. J Virol (2011) 0.94

DNA damage repair genes controlling human papillomavirus (HPV) episome levels under conditions of stability and extreme instability. PLoS One (2013) 0.94

The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer (2015) 0.93

Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis. Cell Death Dis (2012) 0.93

Hitchhiking on host chromatin: how papillomaviruses persist. Biochim Biophys Acta (2012) 0.93

The DNA damage response in viral-induced cellular transformation. Br J Cancer (2012) 0.92

Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication. J Virol (2015) 0.91

The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses (2014) 0.90

Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol (2014) 0.90

Coordinate regulation of DNA damage and type I interferon responses imposes an antiviral state that attenuates mouse gammaherpesvirus type 68 replication in primary macrophages. J Virol (2012) 0.89

The Role of the DNA Damage Response throughout the Papillomavirus Life Cycle. Viruses (2015) 0.89

Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol (2013) 0.89

HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. Virology (2013) 0.89

Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses (2013) 0.89

A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J Virol (2011) 0.88

Human papillomaviruses activate and recruit SMC1 cohesin proteins for the differentiation-dependent life cycle through association with CTCF insulators. PLoS Pathog (2015) 0.87

Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Med (2015) 0.87

Regulation of the life cycle of HPVs by differentiation and the DNA damage response. Future Microbiol (2013) 0.87

Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis. Invest Ophthalmol Vis Sci (2014) 0.86

Baculovirus F-box protein LEF-7 modifies the host DNA damage response to enhance virus multiplication. J Virol (2013) 0.86

At a crossroads: human DNA tumor viruses and the host DNA damage response. Future Virol (2011) 0.86

Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase. J Immunol (2014) 0.86

Virus manipulation of cell cycle. Protoplasma (2011) 0.86

Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J Proteome Res (2014) 0.85

The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses. J Virol (2015) 0.84

Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling. Int J Clin Exp Pathol (2014) 0.84

Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions. Hum Vaccin Immunother (2014) 0.83

SV40 utilizes ATM kinase activity to prevent non-homologous end joining of broken viral DNA replication products. PLoS Pathog (2014) 0.82

Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers (Basel) (2014) 0.82

Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31. J Virol (2015) 0.82

Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression. J Virol (2012) 0.82

The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes. PLoS Pathog (2015) 0.82

Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol (2015) 0.82

Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS One (2015) 0.81

Modulation of the DNA damage response during the life cycle of human papillomaviruses. Virus Res (2016) 0.81

Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells. J Virol (2014) 0.81

STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication. MBio (2015) 0.80

Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide. J Virol (2012) 0.80

Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma. Hum Genet (2011) 0.80

The Rb binding domain of HPV31 E7 is required to maintain high levels of DNA repair factors in infected cells. Virology (2016) 0.79

The Cell Cycle Timing of Human Papillomavirus DNA Replication. PLoS One (2015) 0.79

Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1. J Virol (2015) 0.79

Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation. J Clin Med (2015) 0.79

Targeting human papillomavirus genome replication for antiviral drug discovery. Antivir Ther (2013) 0.78

Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol (2013) 0.78

Design stars: how small DNA viruses remodel the host nucleus. Future Virol (2012) 0.78

Replication of an Autonomous Human Parvovirus in Non-dividing Human Airway Epithelium Is Facilitated through the DNA Damage and Repair Pathways. PLoS Pathog (2016) 0.78

Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival. Biosci Rep (2015) 0.78

HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma. Oncotarget (2015) 0.78

DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication. Viruses (2016) 0.77

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clin Cancer Res (2015) 0.77

CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits. Cancer Res (2014) 0.77

A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication. J Virol (2013) 0.77

The human papillomavirus E7 oncoprotein as a regulator of transcription. Virus Res (2016) 0.76

ATM supports gammaherpesvirus replication by attenuating type I interferon pathway. Virology (2017) 0.76

KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8. Oncogene (2016) 0.76

The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis. PLoS Pathog (2016) 0.76

Human papillomaviruses: research priorities for the next decade. Trends Cancer (2016) 0.76

Involvement of Brd4 in different steps of the papillomavirus life cycle. Virus Res (2016) 0.76

Impact of the DNA Damage Response on Human Papillomavirus Chromatin. PLoS Pathog (2016) 0.76

Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci Rep (2015) 0.76

p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle. J Virol (2014) 0.76

Articles cited by this

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem (1998) 28.13

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (2003) 20.13

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93

A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol (2000) 13.46

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90

ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol (2008) 11.86

The DNA damage response: ten years after. Mol Cell (2007) 11.80

Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res (2004) 9.70

ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science (2005) 8.77

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science (1998) 8.74

Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature (2005) 7.45

H2AX: the histone guardian of the genome. DNA Repair (Amst) (2004) 6.65

The Mre11 complex: at the crossroads of dna repair and checkpoint signalling. Nat Rev Mol Cell Biol (2002) 6.44

ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55

Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science (2004) 4.58

Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol (2001) 4.35

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev (2001) 4.06

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature (2002) 3.99

The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J (2003) 3.91

Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev (2004) 3.76

Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene (2007) 3.68

ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat Genet (2000) 3.49

SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev (2002) 3.49

Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol (2003) 3.12

Epidermal differentiation: the bare essentials. J Cell Biol (1990) 3.11

Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res (2000) 3.06

Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol (1992) 2.99

Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85

Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol (1991) 2.79

Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev (1995) 2.76

The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61

The human papillomavirus E7 oncoprotein. Virology (2008) 2.32

Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol (2004) 2.27

CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? Nat Rev Cancer (2007) 2.21

DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci U S A (2005) 2.20

Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol (2007) 2.12

Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J Virol (2004) 2.01

Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97

Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol (1997) 1.92

Cdc25: mechanisms of checkpoint inhibition and recovery. Trends Cell Biol (2006) 1.84

Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol (1998) 1.81

Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem (2005) 1.63

Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62

Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem (2001) 1.60

Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol Cell Biol (2004) 1.57

E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res (2004) 1.50

The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol (2004) 1.43

Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A (2007) 1.33

Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol (2008) 1.32

Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol (2002) 1.23

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J (2005) 1.21

Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology (1999) 1.14

Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology (2008) 1.10

Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol (2005) 1.03

ATR dependent activation of Chk2. J Cell Physiol (2006) 1.03

DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damage. J Biol Chem (2004) 0.93

Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence. Methods Mol Biol (2005) 0.86

Articles by these authors

Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99

Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22

Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96

Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene (2003) 1.59

Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology (2006) 1.47

Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45

The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol (2004) 1.43

Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37

Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35

Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33

Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A (2007) 1.33

Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol (2006) 1.27

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol (2002) 1.23

Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res (2010) 1.23

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J (2005) 1.21

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology (2009) 1.18

Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol Med (2005) 1.17

Human papillomaviruses target the double-stranded RNA protein kinase pathway. J Gen Virol (2006) 1.16

Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol (2005) 1.16

Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol (2004) 1.11

Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology (2008) 1.10

Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol (2013) 1.09

Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J (2007) 1.08

Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06

The role of human papillomaviruses in oncogenesis. Recent Results Cancer Res (2014) 1.06

Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. J Virol (2007) 1.04

Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol (2005) 1.03

Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31. J Virol (2002) 1.02

The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01

The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology (2007) 1.01

Bap31 is a novel target of the human papillomavirus E5 protein. J Virol (2008) 1.00

Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 0.99

Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J Virol (2010) 0.98

p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol (2011) 0.96

A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology (2011) 0.95

Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol (2007) 0.95

The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95

An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J Virol (2012) 0.91

The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol (2011) 0.90

Regulation of the life cycle of HPVs by differentiation and the DNA damage response. Future Microbiol (2013) 0.87

Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle. Virology (2006) 0.84

Viral transformation of epithelial cells. Methods Mol Biol (2013) 0.75